Additional theory important in the design and evaluation of a periodic screening program is presented. The distributions of doubly bounded preclinical state forward and backward recurrence times of the stochastic screening model are derived. Properties of these distributions are used to obtain an expression for estimating the mean lead time gained by screening, an alternative theoretical expression for the mean lead time and an equation for calculating an estimate of the probability of detecting preclinical disease.
